NAD(P)H dehydrogenase [quinone] 1 isoform 2 [Danio rerio]
NAD(P)H-dependent oxidoreductase( domain architecture ID 10006206)
NAD(P)H-dependent oxidoreductase which catalyzes the reduction or oxidation of a substrate coupled to the oxidation or reduction, respectively, of a nicotinamide adenine dinucleotide cofactor NAD(P)H or NAD(P)+
List of domain hits
Name | Accession | Description | Interval | E-value | ||||
MdaB | COG2249 | Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ... |
6-212 | 2.81e-67 | ||||
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only]; : Pssm-ID: 441850 [Multi-domain] Cd Length: 190 Bit Score: 207.00 E-value: 2.81e-67
|
||||||||
Name | Accession | Description | Interval | E-value | ||||
MdaB | COG2249 | Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ... |
6-212 | 2.81e-67 | ||||
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only]; Pssm-ID: 441850 [Multi-domain] Cd Length: 190 Bit Score: 207.00 E-value: 2.81e-67
|
||||||||
Flavodoxin_2 | pfam02525 | Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ... |
4-212 | 9.00e-52 | ||||
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258. Pssm-ID: 426816 [Multi-domain] Cd Length: 193 Bit Score: 167.90 E-value: 9.00e-52
|
||||||||
PRK09739 | PRK09739 | NAD(P)H oxidoreductase; |
1-127 | 2.02e-17 | ||||
NAD(P)H oxidoreductase; Pssm-ID: 236620 [Multi-domain] Cd Length: 199 Bit Score: 78.21 E-value: 2.02e-17
|
||||||||
Name | Accession | Description | Interval | E-value | ||||
MdaB | COG2249 | Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ... |
6-212 | 2.81e-67 | ||||
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only]; Pssm-ID: 441850 [Multi-domain] Cd Length: 190 Bit Score: 207.00 E-value: 2.81e-67
|
||||||||
Flavodoxin_2 | pfam02525 | Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ... |
4-212 | 9.00e-52 | ||||
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258. Pssm-ID: 426816 [Multi-domain] Cd Length: 193 Bit Score: 167.90 E-value: 9.00e-52
|
||||||||
PRK09739 | PRK09739 | NAD(P)H oxidoreductase; |
1-127 | 2.02e-17 | ||||
NAD(P)H oxidoreductase; Pssm-ID: 236620 [Multi-domain] Cd Length: 199 Bit Score: 78.21 E-value: 2.02e-17
|
||||||||
PRK00871 | PRK00871 | glutathione-regulated potassium-efflux system oxidoreductase KefF; |
84-187 | 1.32e-16 | ||||
glutathione-regulated potassium-efflux system oxidoreductase KefF; Pssm-ID: 234852 Cd Length: 176 Bit Score: 75.59 E-value: 1.32e-16
|
||||||||
PRK04930 | PRK04930 | glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional |
7-212 | 2.86e-16 | ||||
glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional Pssm-ID: 179895 [Multi-domain] Cd Length: 184 Bit Score: 74.65 E-value: 2.86e-16
|
||||||||
PRK00170 | PRK00170 | azoreductase; Reviewed |
67-159 | 3.06e-09 | ||||
azoreductase; Reviewed Pssm-ID: 234675 [Multi-domain] Cd Length: 201 Bit Score: 55.29 E-value: 3.06e-09
|
||||||||
AzoR | COG1182 | FMN-dependent NADH-azoreductase [Energy production and conversion]; |
80-152 | 1.67e-08 | ||||
FMN-dependent NADH-azoreductase [Energy production and conversion]; Pssm-ID: 440795 [Multi-domain] Cd Length: 205 Bit Score: 53.21 E-value: 1.67e-08
|
||||||||
WrbA | COG0655 | Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and ... |
83-151 | 3.71e-07 | ||||
Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and conversion]; Pssm-ID: 440420 [Multi-domain] Cd Length: 181 Bit Score: 49.16 E-value: 3.71e-07
|
||||||||
FMN_red | pfam03358 | NADPH-dependent FMN reductase; |
76-152 | 2.25e-05 | ||||
NADPH-dependent FMN reductase; Pssm-ID: 427259 [Multi-domain] Cd Length: 152 Bit Score: 43.38 E-value: 2.25e-05
|
||||||||
PRK13556 | PRK13556 | FMN-dependent NADH-azoreductase; |
54-154 | 1.48e-03 | ||||
FMN-dependent NADH-azoreductase; Pssm-ID: 184140 [Multi-domain] Cd Length: 208 Bit Score: 38.97 E-value: 1.48e-03
|
||||||||
Blast search parameters | ||||
|